Instadose Pharma Corp
OTC:INSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Reliance Industries Ltd
NSE:RELIANCE
|
IN |
Instadose Pharma Corp
Operating Income
Instadose Pharma Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Instadose Pharma Corp
OTC:INSD
|
Operating Income
-$462k
|
CAGR 3-Years
-170%
|
CAGR 5-Years
-200%
|
CAGR 10-Years
N/A
|
|
|
HG Holdings Inc
OTC:STLY
|
Operating Income
$36k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Instadose Pharma Corp
Glance View
Instadose Pharma Corp. engages in the designing, manufacturing and selling of micro-furniture that transforms any small space, particularly apartments and condominiums into functional spaces. The company is headquartered in Chesapeake, Virginia. The company went IPO on 2019-03-07. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canada’s Global Distribution Platform spans five (5) continent, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include Organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation Participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies; and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents. Its subsidiaries include Instadose Pharma, LDA and Instadose Pharma, LDA.
See Also
What is Instadose Pharma Corp's Operating Income?
Operating Income
-462k
USD
Based on the financial report for Nov 30, 2021, Instadose Pharma Corp's Operating Income amounts to -462k USD.
What is Instadose Pharma Corp's Operating Income growth rate?
Operating Income CAGR 5Y
-200%
Over the last year, the Operating Income growth was -1 698%. The average annual Operating Income growth rates for Instadose Pharma Corp have been -170% over the past three years , -200% over the past five years .
